St. Jude Medical (STJ) Tops Q3 EPS by 1c; Issues Light Q4 Revs Outlook

St. Jude Medical (NYSE: STJ) reported Q3 EPS of $0.97, $0.01 better than the analyst estimate of $0.96. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.39 billion.

St. Jude Medical sees Q4 2014 EPS of $1.02-$1.04, versus the consensus of $1.04. St. Jude Medical sees Q4 2014 revenue of $1.385-1.465 billion, versus the consensus of $1.49 billion.

St. Jude Medical sees FY2014 EPS of $3.97-$3.99, versus the consensus of $3.98. St. Jude Medical sees FY2014 revenue of $5.568-5.648 billion, versus the consensus of $5.69 billion.

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Is Treasury selloff a major issue for stock market bulls?
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities